Evidence map›Paper›PMID 27460083›Full record

ArticleTumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine2016

Neutral endopeptidase (NEP) is differentially involved in biological activities and cell signaling of colon cancer cell lines derived from various stages of tumor development.

Magdalena Mizerska-Kowalska, Agnieszka Bojarska-Junak, Joanna Jakubowicz-Gil, Martyna Kandefer-Szerszeń

Open access · hybridAbstract read
In one paragraph

Article in Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.6field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Neutral endopeptidase depletion decreases colon cancer cell proliferation and TGF-β1 synthesis in indirect co-cultures with normal colon fibroblasts.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Magdalena Mizerska-KowalskaDepartment of Virology and Immunology, Maria Curie-Sklodowska University, Faculty of Biology and Biotechnology, Akademicka 19 Street, 20-033, Lublin, Poland. magdalena.mizerska-dudka@poczta.umcs.lublin.pl.
Agnieszka Bojarska-JunakChair and Department of Clinical Immunology, Medical University of Lublin, W.Chodźki 4a Street, Lublin, Poland.
Joanna Jakubowicz-GilDepartment of Comparative Anatomy and Anthropology, Maria Curie-Sklodowska University, Faculty of Biology and Biotechnology, Akademicka 19 Street, 20-033, Lublin, Poland.
Martyna Kandefer-SzerszeńDepartment of Virology and Immunology, Maria Curie-Sklodowska University, Faculty of Biology and Biotechnology, Akademicka 19 Street, 20-033, Lublin, Poland.
Maria Curie-Skłodowska University · PLMedical University of Lublin · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The presented studies were aimed at exploring the role of neutral endopeptidase (NEP) in the function of colon cancer cell lines LS 180 and SW 620, derived from different grades and stages of tumor development. NEP silencing by siRNA resulted in decreased viability and proliferation accompanied by increased apoptosis in both cell lines. Additionally, cell cycle arrest at the G2/M phase was observed, but only in LS 180 cells. Opposite to these results, serum-stimulated migration was increased in both cell lines. Furthermore, NEP silencing influenced the invasive activity of LS 180 and SW 620 cells in an opposite manner: while LS 180 cells showed an enhanced invasiveness, SW 620 cells exerted a reduced activity. An exploration of the activity of signaling molecules responsible for the function of tumor cells-Akt, PTEN, and FAK-after NEP silencing indicated that the endopeptidase is involved in their regulation. The increased phosphorylation level of Akt was accompanied by a decrease in PTEN in the presence of a high concentration of serum. A reduced concentration of serum did not change the phosphorylation status of Akt. Enhanced autophosphorylation of FAK was observed in LS 180 and SW 620 cells cultivated in a medium with a high concentration of serum. Taken together, these results confirm that NEP is implicated in the regulation of the survival, growth, and motile activity of colon cancer. This is also the first report which shows that NEP mediates cancer cell migration and invasiveness, but not growth and survival, through Akt/FAK signaling pathways.

Indexed as

Signal TransductionApoptosisCell CycleCell Line, TumorCell MovementCell ProliferationCell Transformation, NeoplasticColonic NeoplasmsFocal Adhesion Protein-Tyrosine KinasesGene Expression Regulation, NeoplasticGene SilencingHumansNeoplasm GradingNeoplasm StagingNeprilysinPhosphorylationFocal Adhesion Protein-Tyrosine KinasesNeprilysinProto-Oncogene Proteins c-aktPTEN PhosphohydrolaseAkt/PTENApoptosisCell cycleColon cancerFAKNEPNeutral endopeptidase

Identifiers

PMID27460083
PMCPMC5097095
OpenAlexW2488619794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.